GlassScriptPhysician profile
Khalid S Mahran
NPI 1336253210
$860.87
in general payments reported to CMS, 2019-2025
17 companies · $798 in 2025
The $798 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $62.80 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $860.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $138.09 | 2025 | |
| Amgen INC. | $124.99 | 2025 | Tavneos |
| Apellis Pharmaceuticals, INC. | $104.21 | 2025 | |
| Lilly USA, LLC | $81.01 | 2025 | Jardiance, Mounjaro |
| Novartis Pharmaceuticals Corporation | $70.67 | 2024-2025 | |
| Insulet Corporation | $55.73 | 2024-2025 | Omnipod |
| Abbvie INC. | $45.02 | 2025 | |
| Novo Nordisk INC | $38.43 | 2025 | Ozempic, Wegovy |
| Boston Scientific Corporation | $37.42 | 2025 | Watchman Flx |
| Mannkind Corporation | $33.65 | 2025 | |
| Sequel Med Tech, LLC | $27.90 | 2025 | Twiist |
| Pfizer INC. | $20.77 | 2025 | |
| Pharming Healthcare, INC. | $19.42 | 2025 | Ruconest |
| Abbott Laboratories | $19.24 | 2025 | Freestyle Libre 3 |
| Exact Sciences Corporation | $15.74 | 2025 | The Cologuard Plus Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cepheid | $14.99 | 2025 | |
| Ascensia Diabetes Care US INC. | $13.59 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalid Mahran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.